Publication number: 20240197715
Abstract: The present invention provides a pharmaceutical combination comprising a WRN inhibitor in combination with at least one additional therapeutically active agent. It also provides a method of treating cancer, involving administering to a subject in need thereof the WRN inhibitor in combination with the at least one additional therapeutically active agent. For example, the WRN inhibitor compound, or a pharmaceutically acceptable salt thereof, is of formula (I): wherein R1, R2, R3, R4, R5, R28, R27, y, R, M, W, L, V, T, Y, J, K and A are as described herein.
Type:
Application
Filed:
November 16, 2023
Publication date:
June 20, 2024
Inventors:
Rita ANDRAOS-REY, Sandra BLUM-KALLERT, Marta CORTES-CROS, Ruben DE KANTER, Stephane FERRETTI, Isabel Cristina Colaco Farias JACO, Jacques HAMON, Jürgen Hans-Hermann HINRICHS, Laurent LABORDE, Henrik MOEBITZ, Michele MOSCHETTA, Joseph SCHOEPFER, Ross Sinclair STRANG